Federal grant
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Closes in 371 days Oct 15, 2027
In plain English
Support early testing of new drug and device treatments for mental health conditions.
The National Institutes of Health is offering this grant.
Free account needed
Read this grant in full
Who can apply, the amounts, the full description, the contact, and the official notice are one free account away.
A free account gives you:
- Read every bid and grant in full, with the official notice
- See how each bid compares with your business
- New bids that fit your work, by email once a week
- A first look at a bid from our AI assistant, one bid a day
- The readiness check, the certification checks and your results saved
It takes about a minute. No card is asked for, and we never sell your email address.
OpenBid shows public federal data from Grants.gov and is not a government website. OpenBid cannot guarantee that any applicant will receive a grant. Always confirm dates and requirements on the official listing before you apply.